VITAMIN E FOR THE TREATMENT OF DISEASES IN WHICH INHIBITING THE BINDING OF THE TRANSCRIPTION FACTOR NF-$G(K)B AND/OR AP-1 TO PROMOTER TARGET SITES HAS A BENEFICIAL EFFECT

Details for Australian Patent Application No. 2002321176 (hide)

Owner DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES EFFENTLICHEN RECHTS

PCT Number PCT/EP02/07446

Filing date 5 July 2002

Event Publications

16 January 2003 Complete Application Filed

17 July 2003 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(3)/See Reg. 8.3(2). This application was not yet Open to Public Inspection. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002321177-IMPROVED ARRANGEMENT FOR FASTENING A FOOTWEAR TO A PIECE OF SPORTS EQUIPMENT

2002321175-SUPPORT ELEMENT FOR AN OPTICAL MODULE AND AN OPTICAL MODULE